Genentech Inc

1 products tracked · names used in filings: Genentech Inc

Upcoming milestones

No upcoming milestones listed.

Recent milestones

Mon 16 Nov 2026🇺🇸 FDA approval

FDA approves Wilserdly (giredestran), a new medicine

Genentech Inc; NDA220791; New molecular entity; capsule · source

Products

ProductStatusApproved
🇺🇸Wilserdly
giredestran
Approved2026-11-16

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.